surpass-cvot tirzepatide 💡 New insight in diabetes care: In patients with T2DM and ASCVD, the trial found that was noninferior to dulaglutide for major cardiovascular events (12.2% vs 13.1%; HR 0.92). What Tirzepatide vs Dulaglutide in T2D:

The starting dose is ultra-low (0.25 mg) and is increased very slowly because Only after at least 16 weeks of increasing the dose gradually, you reach the most effective weight-loss dosage of 2.4 mg injected per week

Overall Health : A persons overall health and the presence of any underlying medical conditions can affect the absorption and utilization of Vitamin B12

Tirzepatide: a Novel, once-weekly dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes

Between them, tirzepatide is the more effective option for its dual mechanisms of action

The exploration of the mechanism of the metabolites from TCM drugs in cancer prevention and treatment, or optimization of good anti-tumor drugs from TCM drugs, has become a major research focus